Literature DB >> 16391521

Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog.

Jung Sun Kim1, Jiha Kim, Byung Soo Kim, Hee Yong Chung, Young Yiul Lee, Choon Sik Park, Young Seek Lee, Young Han Lee, Il Yup Chung.   

Abstract

Nanog, a homeodomain (HD) transcription factor, plays a critical role in the maintenance of embryonic stem (ES) cell self-renewal. Here, we report the identification of an alternatively-spliced variant of nanog. This variant lacked a stretch of amino acids (residues 168-183) located between the HD and tryptophan-repeat (WR) of the previously-reported full length sequence, suggesting that the deleted sequence functions as a linker and possibly affects the flexibility of the C-terminal transactivation domain relative to the DNA binding domain. Expression of mRNA encoding the splice variant, designated as nanog-delta 48, was much lower than that of the full length version in human ES cells. The ratio of nanog-delta 48 transcript to full length transcript increased, however, in multipotent adult progenitor cells. EMSA analysis revealed that both forms of Nanog were able to bind a nanog binding sequence with roughly the same affinity. A reporter plasmid assay also showed that both variants of nanog modestly repressed transactivation of gata-4, whose expression is proposed to be inhibited by nanog, with comparable potency. We conclude that, despite the difference in primary structure and expression pattern in various stem cells, the alternatively-spliced variant of Nanog has similar activity to that of the full length version.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16391521     DOI: 10.1038/emm.2005.73

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  6 in total

1.  Ultrasensitive nanostructured immunosensor for stem and carcinoma cell pluripotency gatekeeper protein NANOG.

Authors:  Bhaskara V Chikkaveeraiah; Alice Soldà; Dharamainder Choudhary; Flavio Maran; James F Rusling
Journal:  Nanomedicine (Lond)       Date:  2012-03-06       Impact factor: 5.307

2.  Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells.

Authors:  Irina Eberle; Birgit Pless; Miriam Braun; Theo Dingermann; Rolf Marschalek
Journal:  Nucleic Acids Res       Date:  2010-04-28       Impact factor: 16.971

3.  Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.

Authors:  Monika Kuciak; Christophe Mas; Isabel Borges; Pilar Sánchez-Gómez; Ariel Ruiz I Altaba
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

4.  Colon cancer cell differentiation by sodium butyrate modulates metabolic plasticity of Caco-2 cells via alteration of phosphotransfer network.

Authors:  Ljudmila Klepinina; Aleksandr Klepinin; Laura Truu; Vladimir Chekulayev; Heiki Vija; Kaisa Kuus; Indrek Teino; Martin Pook; Toivo Maimets; Tuuli Kaambre
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

5.  Nanog retrotransposed genes with functionally conserved open reading frames.

Authors:  Morag Robertson; Frances Stenhouse; Douglas Colby; Jamie R K Marland; Jennifer Nichols; Susan Tweedie; Ian Chambers
Journal:  Mamm Genome       Date:  2006-07-14       Impact factor: 2.957

6.  Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.

Authors:  Bigang Liu; Mark D Badeaux; Grace Choy; Dhyan Chandra; Irvin Shen; Collene R Jeter; Kiera Rycaj; Chia-Fang Lee; Maria D Person; Can Liu; Yueping Chen; Jianjun Shen; Sung Yun Jung; Jun Qin; Dean G Tang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.